NATH BIOGENES (INDIA) Financial Statement Analysis
|
||
|
The Revenues of NATH BIOGENES (INDIA) have increased by 11.13% YoY .
The Earnings Per Share (EPS) of NATH BIOGENES (INDIA) has increased by Positive YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
NATH BIOGENES (INDIA) Last 5 Annual Financial Results
[BOM: 537291|NSE : NATHBIOGEN]
| Consolidated | Mar2023 | Mar2022 | Mar2013 | Mar2012 |
|---|---|---|---|---|
| Revenues | ₹13,770,298 Cr | ₹12,391,533 Cr | ₹124 Cr | ₹124 Cr |
| Expenses | ₹11,780,424 Cr | ₹10,924,203 Cr | ₹109 Cr | ₹109 Cr |
| Operating Profit (Excl OI) | ₹1,989,874 Cr | ₹1,467,330 Cr | ₹15 Cr | ₹15 Cr |
| Other Income | ₹58,025 Cr | ₹90,801 Cr | ₹0.91 Cr | ₹0.91 Cr |
| Interest | ₹367,298 Cr | ₹180,633 Cr | ₹1.81 Cr | ₹1.81 Cr |
| Depreciation | ₹450,988 Cr | ₹469,996 Cr | ₹4.70 Cr | ₹4.70 Cr |
| Profit Before Tax | ₹1,229,613 Cr | ₹907,503 Cr | ₹9.08 Cr | ₹9.08 Cr |
| Profit After Tax | ₹1,174,569 Cr | ₹920,064 Cr | ₹9.20 Cr | ₹9.20 Cr |
| Consolidated Net Profit | ₹1,174,569 Cr | ₹920,064 Cr | ₹9.20 Cr | ₹9.20 Cr |
| Earnings Per Share (Rs) | ₹18.43 | ₹-35.46 | ₹7.34 | ₹5.75 |
| PAT Margin (%) | 11.62 | -24.21 | 8.53 | 7.42 |
| ROE(%) | 6.28 | -22.48 | 22.76 | 20.12 |
| ROCE(%) | 7.06 | -14.84 | 23.88 | 19.09 |
| Total Debt/Equity(x) | 0.18 | 0.17 | 0.33 | 0.25 |
Key Financials |
||
| Market Cap | : | ₹ 363.0 Cr |
| Revenue (TTM) | : | ₹ 334.6 Cr |
| Net Profit(TTM) | : | ₹ 40.5 Cr |
| EPS (TTM) | : | ₹ 21.3 |
| P/E (TTM) | : | 9.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| NATH BIOGENES (INDIA) | 0.8% | -15.2% | 27.9% |
| BOMBAY BURMAH TRADING CORPORATION | 1.9% | -9.3% | 86.3% |
| KAVERI SEED COMPANY | -1.5% | -5.4% | 22.2% |
| VENKYS (INDIA) | -0.4% | -13.5% | -1.3% |
| BOMBAY SUPER HYBRID SEEDS | NA | -11.6% | -31.3% |
| TIERRA AGROTECH | 3.7% | -21.5% | -47.8% |
| INDO US BIOTECH | -12.2% | -26.8% | 173% |
| MANGALAM SEEDS | NA | NA | NA |
| SHREE OSWAL SEEDS AND CHEMICALS | -9.4% | -19.3% | -35.2% |
NATH BIOGENES (INDIA) Revenues
[BOM: 537291|NSE : NATHBIOGEN]
| Y-o-Y | 11.13 % |
| 5 Yr CAGR | 4,707.73 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹13,770,298 Cr | 11.13 | |
| Mar2022 | ₹12,391,533 Cr | 9,999,926.49 | |
| Mar2013 | ₹124 Cr | 0.00 | |
| Mar2012 | ₹124 Cr | - | |
NATH BIOGENES (INDIA) Operating Profit
[BOM: 537291|NSE : NATHBIOGEN]
| Y-o-Y | 35.61 % |
| 5 Yr CAGR | 5,037.70 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,989,874 Cr | 35.61 | |
| Mar2022 | ₹1,467,330 Cr | 10,000,106.64 | |
| Mar2013 | ₹15 Cr | 0.00 | |
| Mar2012 | ₹15 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 22.04 % |
| 5 Yr CAGR | 6.87 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 14.45% | 22.04 | |
| Mar2022 | 11.84% | 0.00 | |
| Mar2013 | 11.84% | 0.00 | |
| Mar2012 | 11.84% | - | |
NATH BIOGENES (INDIA) Profit After Tax
[BOM: 537291|NSE : NATHBIOGEN]
| Y-o-Y | 27.66 % |
| 5 Yr CAGR | 4,935.17 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,174,569 Cr | 27.66 | |
| Mar2022 | ₹920,064 Cr | 9,999,504.72 | |
| Mar2013 | ₹9.20 Cr | 0.00 | |
| Mar2012 | ₹9.20 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | 16.13 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 11.62 % | Positive | |
| Mar2022 | -24.21 % | Negative | |
| Mar2013 | 8.53 % | 14.96 | |
| Mar2012 | 7.42 % | - | |
NATH BIOGENES (INDIA) Earnings Per Share (EPS)
[BOM: 537291|NSE : NATHBIOGEN]
| Y-o-Y | Positive |
| 5 Yr CAGR | 47.44 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹18 | Positive | |
| Mar2022 | ₹-35 | Negative | |
| Mar2013 | ₹7.34 | 27.65 | |
| Mar2012 | ₹5.75 | - | |
NATH BIOGENES (INDIA) Return on Capital Employed (ROCE)
[BOM: 537291|NSE : NATHBIOGEN]
| Y-o-Y | Positive |
| 5 Yr CAGR | -28.22 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 7.06% | Positive | |
| Mar2022 | -14.84% | Negative | |
| Mar2013 | 23.88% | 25.09 | |
| Mar2012 | 19.09% | - | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Current Share Price | : | ₹191.1 |
| Current MarketCap | : | ₹ 363.0 Cr |
| Updated EOD on | : | Apr 19,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 0.8% |
-15.2% |
27.9% |
| SENSEX | -2.6% |
-0% |
21% |
NATH BIOGENES (INDIA) related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about NATH BIOGENES (INDIA) Financials
How the annual revenues of NATH BIOGENES (INDIA) have changed ?
The Revenues of NATH BIOGENES (INDIA) have increased by 11.13% YoY .
How the Earnings per Share (EPS) of NATH BIOGENES (INDIA) have changed?
The Earnings Per Share (EPS) of NATH BIOGENES (INDIA) has increased by Positive YoY .
Check out Intrinsic Value of Peers of NATH BIOGENES (INDIA)
Compare Stock Analytics of Peers of NATH BIOGENES (INDIA)
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs
